Tokgoz, OrhanSahin, AlparslanTufek, AdnanCinar, YasinGuzel, AbdulmenapCiftci, TanerCelik, Feyzi2024-04-242024-04-2420132314-61332314-6141https://doi.org/10.1155/2013/435387https://hdl.handle.net/11468/17875Bacground. To investigate the anesthetic management in premature infants with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB) injections. Methods. A retrospective chart review was performed for the patients with ROP who had IVB injection. Clinical characteristics, demographic variables, anesthetic medications, operation techniques, time intervals, and complications were recorded. Results. Sixty-six eyes of 33 patients (23 males, 10 females) with type 1 ROP who were treated with IVB were included. A total of 66 anesthetic applications were performed. Mean gestational age at birth was 28.3 weeks (range 25-33). Mean birth weight was 1300 g (range 600-1850). Serious ocular and systemic complications were not observed in any infant. Conclusion. Inhalation anesthesia with sevoflurane during IVB treatment in premature infants with ROP may be appropriate for anesthetic management.eninfo:eu-repo/semantics/openAccess[No Keyword]Article2013WOS:0003205551000012-s2.0-848793402412384107010.1155/2013/435387Q1Q4